Literature DB >> 30532890

Complete disappearance of red thrombi in a drug-eluting stent despite discontinuation of antiplatelet therapy: Angioscopic confirmation.

Daisuke Murakami1, Masamichi Takano1, Masanori Yamamoto1, Nobuaki Kobayashi2, Shinya Yokoyama2, Yoshihiko Seino1, Kyoichi Mizuno3.   

Abstract

We present the case of a 48-year-old man with unstable angina who underwent drug-eluting stent (DES) implantation for the left circumflex artery (LCx). Red thrombi within the stent were clearly found by coronary angioscopy. Dual antiplatelet therapy was orally given before the stenting. Twenty-two months after the procedure, the patient visited because of severe chest pain. The patient had stopped taking all prescriptions including antiplatelet drugs for the previous 18 months. The occurrence of late stent thrombosis (LST) derived from previously implanted DES in the LCx was strongly suspected. Unexpectedly, the left coronary angiograms showed neither in-stent restenosis nor thrombotic occlusion. Angioscopic images for the DES segment showed that there were no uncovered stent struts without neointimal coverage. Notably, red thrombi identified immediately after stenting by angioscopy had completely disappeared. Mural red thrombi at the first observation completely disappeared despite premature cessation of dual antiplatelet therapy. Early neointimal coverage may occasionally occur even under the condition of acute coronary syndrome. The leading cause of LST was not only the cessation of dual-antiplatelet therapy and multiple factors contribute to LST of DES. Relatively early and adequate neointimal stent coverage may reduce the risk of thrombus formation including LST even though anti-platelet therapy was discontinued prematurely.

Entities:  

Keywords:  Coronary angioscopy; Drug-eluting stent; Dual antiplatelet therapy; Stent thrombosis

Year:  2011        PMID: 30532890      PMCID: PMC6265215          DOI: 10.1016/j.jccase.2011.09.008

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  9 in total

1.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

2.  Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.

Authors:  Fusako Sera; Masaki Awata; Masaaki Uematsu; Jun-ichi Kotani; Shinsuke Nanto; Seiki Nagata
Journal:  JACC Cardiovasc Interv       Date:  2009-10       Impact factor: 11.195

3.  Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.

Authors:  Peter Wenaweser; Joost Daemen; Marcel Zwahlen; Ron van Domburg; Peter Jüni; Sophia Vaina; Gerrit Hellige; Keiichi Tsuchida; Cyrill Morger; Eric Boersma; Neville Kukreja; Bernhard Meier; Patrick W Serruys; Stephan Windecker
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

4.  Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation.

Authors:  Kenichi Fujii; Daizo Kawasaki; Katsumi Oka; Hirokuni Akahori; Masashi Fukunaga; Hisashi Sawada; Motomaru Masutani; Masaaki Lee-Kawabata; Takeshi Tsujino; Mitsumasa Ohyanagi; Tohru Masuyama
Journal:  Heart       Date:  2010-12-30       Impact factor: 5.994

Review 5.  Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.

Authors:  Jun-ichi Kotani; Masaki Awata; Shinsuke Nanto; Masaaki Uematsu; Fusako Oshima; Hitoshi Minamiguchi; Gary S Mintz; Seiki Nagata
Journal:  J Am Coll Cardiol       Date:  2006-04-04       Impact factor: 24.094

6.  Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.

Authors:  Nobuyoshi Tanaka; Mitsuyasu Terashima; Sudhir Rathore; Tsuyoshi Itoh; Maoto Habara; Kenya Nasu; Masashi Kimura; Tatsuya Itoh; Yoshihisa Kinoshita; Mariko Ehara; Etsuo Tsuchikane; Keiko Asakura; Yasushi Asakura; Osamu Katoh; Takahiko Suzuki
Journal:  JACC Cardiovasc Interv       Date:  2010-10       Impact factor: 11.195

7.  Vulnerable disease may induce neointimal coverage after sirolimus-eluting stent implantation.

Authors:  Masami Nishino; Shiro Hoshida; Masayuki Taniike; Hiroyasu Kato; Yasuyuki Egami; Ryu Shutta; Hitoshi Yamaguchi; Kenjiro Tanaka; Jun Tanouchi; Yoshio Yamada
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

8.  Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy.

Authors:  Masamichi Takano; Masanori Yamamoto; Yong Xie; Daisuke Murakami; Shigenobu Inami; Kentaro Okamatsu; Koji Seimiya; Takayoshi Ohba; Yoshihiko Seino; Kyoichi Mizuno
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

9.  Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.

Authors:  Masanori Yamamoto; Kentaro Okamatsu; Shigenobu Inami; Masamichi Takano; Shinya Yokoyama; Takayoshi Ohba; Chikao Ibuki; Noritake Hata; Yoshihiko Seino; Kyoichi Mizuno
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.